These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7619669)

  • 1. Twenty-four hour efficacy of two dose levels of a once daily sustained-release diltiazem formulation in stable angina: a placebo-controlled trial. The Dildurang Study Group.
    Frances Y; Gagey S; Stalla-Bourdillon A
    Br J Clin Pharmacol; 1995 Mar; 39(3):277-82. PubMed ID: 7619669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy and safety of once-daily diltiazem in patients with stable angina pectoris switched from twice-daily diltiazem.
    Savard D; Lenis J; Juneau M; Jacob C; Boulet AP
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):85-9. PubMed ID: 7564371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of sustained-release diltiazem in stable angina pectoris.
    Weiner DA; Cutler SS; Klein MD
    Am J Cardiol; 1986 Jan; 57(1):6-9. PubMed ID: 3510525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antianginal efficacy and safety of controlled-delivery diltiazem QD versus an equivalent dose of immediate-release diltiazem TID.
    Klinke WP; Baird M; Juneau M; Waters D; Warnica W; Lakhani Z; Annable L; Boulet AP; Larivière L
    Cardiovasc Drugs Ther; 1995 Apr; 9(2):319-30. PubMed ID: 7662599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, placebo-controlled trial of sustained-release diltiazem in patients with angina. Sustained-Release Diltiazem Study Group.
    Weiss RJ; Hicks D; Bittar N; Bowers J; Shah A
    Clin Ther; 1993; 15(6):1069-75. PubMed ID: 8111804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antianginal efficacy over 24 hours and exercise hemodynamic effects of once daily sustained-release 300 mg diltiazem and 240 mg verapamil in stable angina pectoris.
    De Rosa ML; Giordano A; Melfi M; Della Guardia D; Ciaburri F; Rengo F
    Int J Cardiol; 1998 Jan; 63(1):27-35. PubMed ID: 9482142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved efficacy and safety of controlled-release diltiazem compared to nifedipine may be related to its negative chronotropic effect.
    Basu SK; Kinsey CD; Miller AJ; Lahiri A
    Am J Ther; 2000 Jan; 7(1):17-22. PubMed ID: 11319569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of a once-daily graded-release diltiazem formulation dosed at bedtime compared to placebo and to morning dosing in chronic stable angina pectoris.
    Glasser SP; Gana TJ; Pascual LG; Albert KS
    Am Heart J; 2005 Feb; 149(2):e1-9. PubMed ID: 15846251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mibefradil in the treatment of chronic stable angina pectoris: comparative studies with other calcium antagonists.
    Davies GJ; Tzivoni D; Kobrin I
    Am J Cardiol; 1997 Aug; 80(4B):34C-39C. PubMed ID: 9286852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of diltiazem standard formulation and diltiazem controlled release in patients with stable angina pectoris: a randomized, double-blind, cross-over, multicenter study.
    Vliegen HW; van der Wall EE; Kragten JA; Holwerda NJ; Schenkel WM; Muijs van de Moer WM; ten Kate JB; Mulder PG; Bruschke AV
    J Cardiovasc Pharmacol; 1993 Apr; 21(4):552-9. PubMed ID: 7681899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of sustained-release diltiazem for stable angina pectoris.
    Klinke WP; Juneau M; Grace M; Kostuk WJ; Pflugfelder P; Maranda CR; Warnica W; Chin C; Annable L; Dempsey EE
    Am J Cardiol; 1989 Dec; 64(19):1249-52. PubMed ID: 2511743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antianginal response to once-daily diltiazem CD in patients receiving concomitant beta-blockers, long-acting nitrates, or both. Diltiazem CD Study Group.
    Heller GV; Sridharan M; Morse J; Glasser S; Beach CL
    Pharmacotherapy; 1997; 17(4):760-6. PubMed ID: 9250554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The antianginal effects of a new delayed-release formulation of diltiazem in patients with stable angina pectoris: its evaluation by the ergometry test and dynamic electrocardiogram].
    Metra M; Catalano A; Danesi R; Furloni R; Cuminetti S; Bellandi M; Dei Cas L
    Cardiologia; 1992 Jun; 37(6):403-11. PubMed ID: 1394348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of nisoldipine and diltiazem in the treatment of effort angina pectoris].
    de Caprio L; Sestito M; Pandolfi E; Santamaria F; di Palma A; Lombardi L; Voza A; De Rosa ML; Cicatiello AM; Rengo F
    G Ital Cardiol; 1994 Feb; 24(2):115-22. PubMed ID: 8013763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of diltiazem and nifedipine for both angina pectoris and systemic hypertension.
    Frishman WH; Charlap S; Goldberger J; Kimmel B; Stroh J; Dorsa F; Allen L; Strom J
    Am J Cardiol; 1985 Dec; 56(16):41H-46H. PubMed ID: 3934948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-ranging study of a new, once-daily diltiazem formulation for patients with stable angina.
    Cutler NR; Eff J; Fromell G; Brass EP; Archer S; Chrysant SG; Fiddes R
    J Clin Pharmacol; 1995 Feb; 35(2):189-95. PubMed ID: 7751431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of the 200-300 mg sustained release formulation of diltiazem administered once daily in patients with stable angina.
    Trimarco B; Radzik D; Van Mieghem W; Neveux E; Wajman A; Attali P; Ponsonnaille J
    Eur J Clin Pharmacol; 1995; 47(6):493-6. PubMed ID: 7768250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind, randomized study of the anti-anginal and anti-ischaemic efficacy of fendiline and diltiazem in patients with coronary heart disease.
    Schulz J; Lubnau E; Grossmann M; Rück W
    Curr Med Res Opin; 1991; 12(8):521-39. PubMed ID: 1764956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response evaluation of once-daily therapy with a new formulation of diltiazem for stable angina pectoris. Diltiazem CD Study Group.
    Thadani U; Glasser S; Bittar N; Beach CL
    Am J Cardiol; 1994 Jul; 74(1):9-17. PubMed ID: 8017316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.